Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “asthma”

Tapering of Inhaled Corticosteroids in Tezepelumab-treated Asthma patieNts: Impact on Clinical OutcomesEnrolling By Invitation
NCT07713498N/AUpdated Jul 21, 2026
Sponsor: Franciscus Gasthuis
Severe Asthma
Netherlands
Effect of Linvemastat in Patients With Partially Controlled Asthma (syMMPonia)Not Yet Recruiting
NCT07191535Phase 2Updated Jul 20, 2026
Sponsor: Foresee Pharmaceuticals Co., Ltd.
Asthma (Diagnosis) · Pulmonary Function · Moderate-to-Severe Asthma
Comparative Real World Effectiveness of SQ Sublingual Immunotherapy (SLIT)-Tablets vs. Controls in Allergic Rhinitis and AsthmaCompleted
NCT05476484N/AUpdated Jul 20, 2026
Sponsor: ALK-Abelló A/S
Allergic Rhinitis · Asthma · Allergy
Denmark
Innovative Steroid Treatment to Reduce Asthma Development in Children After First-time Rhinovirus Induced WheezingRecruiting
NCT03889743Phase 4Updated Jul 20, 2026
Sponsor: St. Olavs Hospital
Asthma · Inflammation
Finland, Norway, Sweden
A Research Study of House Dust Mite (HDM) SLIT-tablet for the Treatment of HDM Allergy in Chinese Participants Aged 12-65Active Not Recruiting
NCT07060885Phase 3Updated Jul 20, 2026
Sponsor: ALK-Abelló A/S
Allergic Rhinoconjunctivitis · Allergic Rhinitis
China
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled CorticosteroidsRecruiting
NCT06932263Phase 2Updated Jul 20, 2026
Sponsor: AstraZeneca
Asthma
United States, Argentina, Brazil, Chile, China +16 more
Observational Study on the Clinical Profile of Patients With Uncontrolled Severe Asthma Treated With Tezepelumab in ItalyActive Not Recruiting
NCT06948396N/AUpdated Jul 20, 2026
Sponsor: AstraZeneca
Asthma
Italy
A Study Testing the Superiority of CHF 1535 pMDI 800/24µg Total Daily Dose Compared With CHF 718 pMDI 800µg Total Daily Dose in Adults With Asthma on Medium or High-Dose Inhaled CorticosteroidCompleted
NCT05292586Phase 3Updated Jul 20, 2026
Sponsor: Chiesi Farmaceutici S.p.A.
Asthma
United States
Description of Characteristics, Such as Age, Previous and Concurrent Treatments, Associated Diseases, of Patients With Asthma Treated With Dupilumab (DUPIXENT)Completed
NCT04550962N/AUpdated Jul 20, 2026
Sponsor: Sanofi
Asthma
Argentina, Chile, Colombia, Israel, Kuwait +7 more
A Study of Lebrikizumab in Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller MedicationCompleted
NCT01867125Phase 3Updated Jul 17, 2026
Sponsor: Hoffmann-La Roche
Asthma
United States, Argentina, Australia, Belgium, Canada +21 more
A Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-UpRecruiting
NCT06732414N/AUpdated Jul 17, 2026
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Allergy, Sinus Disorders, Atopic Diseases, Asthma, Allergic Rhinitis, Atopic Dermatitis, EoE, Drug a
United States
PULmonary Stimulation for Asthma ReliefNot Yet Recruiting
NCT07709754NAUpdated Jul 17, 2026
Sponsor: Spiro Medical, Inc.
Moderate to Severe Asthma
United States
A Study Evaluating the Efficacy and Safety of Lebrikizumab in Adult Patients With Mild to Moderate AsthmaCompleted
NCT02104674Phase 3Updated Jul 17, 2026
Sponsor: Hoffmann-La Roche
Asthma
United States, Brazil, Bulgaria, Canada, Czechia +6 more
Tezepelumab in the Treatment of Emergency Room Asthma in Adults (TERAA)Recruiting
NCT06705764Phase 4Updated Jul 17, 2026
Sponsor: University of Alberta
Severe Asthma
Canada
A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic AsthmaActive Not Recruiting
NCT05692180Phase 3Updated Jul 17, 2026
Sponsor: AstraZeneca
Asthma
United States, Argentina, France, Italy, Poland +4 more
Combination Short-Acting BroNchodilator and Inhaled Corticosteroid Rescue Therapy on Health Outcomes in Routine CareActive Not Recruiting
NCT06422689Phase 4Updated Jul 16, 2026
Sponsor: AstraZeneca
Asthma
United States
Effectiveness and Safety Study of Tezepelumab in Adults & Adolescent Participants With Severe Asthma in the United StatesCompleted
NCT05329194Phase 4Updated Jul 16, 2026
Sponsor: AstraZeneca
Asthma
United States
Anakinra Rescue Treatment for Moderate Asthma Attacks (ARTMA)Not Yet Recruiting
NCT07600190Phase 1Updated Jul 15, 2026
Sponsor: University of North Carolina, Chapel Hill
Asthma (Diagnosis) · Persistent Asthma · Moderate Asthma Exacerbation
United States
A Study to Investigate How Budesonide and Formoterol Move Through the Body (Pharmacokinetics) When Delivered With Different Devices in Participants Aged 4 to Less Than 12 Years Old With AsthmaCompleted
NCT07433569Phase 1Updated Jul 15, 2026
Sponsor: AstraZeneca
Asthma
United States
Impact of Metabolic Dysfunction and Mucus Plugging on Asthma PhysiologyActive Not Recruiting
NCT05757583N/AUpdated Jul 14, 2026
Sponsor: University of California, San Francisco
Asthma
United States
Prospective Multicentre Study on Symptoms in First-onset Bronchial Asthma in Children and AdolescentsRecruiting
NCT06201494N/AUpdated Jul 14, 2026
Sponsor: Charles University, Czech Republic
Asthma · Asthma in Children · Dyspnea · Cough
Czechia
Effect of Chromium Weight Reduction on Adult Asthma ControlNot Yet Recruiting
NCT07703358NAUpdated Jul 14, 2026
Sponsor: Cairo University
Asthma Chronic · Bronchial Asthma
A Study Comparing a Pre-filled Safety Syringe and an Autoinjector for SHR-1703 Injection in Healthy ParticipantsNot Yet Recruiting
NCT07701239Phase 1Updated Jul 14, 2026
Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd
Asthma With Eosinophilic Phenotype
China
Administration of ARS-1 or Albuterol in Subjects With Persistent AsthmaCompleted
NCT05363670Phase 2Updated Jul 14, 2026
Sponsor: ARS Pharmaceuticals, Inc.
Asthma
United States
Y of Central Maryland Head Start Asthma ImplementationRecruiting
NCT05004714N/AUpdated Jul 13, 2026
Sponsor: Johns Hopkins University
Asthma in Children · Implementation · Preschool Children
United States

Previous page Next page